This page includes the latest FDA filings for Arch Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | OTHER OTC Market | ARTH | DUNS 781725705 |
Device Company | Device | Date |
---|---|---|
Arch Therapeutics, Inc. | AC5 Topical Gel | 2020-03-11 |
Arch Therapeutics, Inc. | AC5 Topical Gel | 2018-12-14 |
NCAGE Code | 4LGA3 | ARCH THERAPEUTICS, INC. |
CAGE Code | 4LGA3 | ARCH THERAPEUTICS, INC. |
S.A.M. Registration | 4LGA3 [781725705] | ARCH THERAPEUTICS, INC. |
SEC | 0001537561 | Arch Therapeutics, Inc. of NEVADA |
SEC | 0001502523 | Arch Therapeutics, Inc. of MASSACHUSETTS |
SEC | 1537561 | Arch Therapeutics, Inc. of NEVADA |